JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Atopic Dermatitis Flare Following Initiation of Nemolizumab

Published online July 27, 2026

Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by intense pruritus and recurrent flares.1 Despite advanc...

read more
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

Published online July 27, 2026

Psoriasis is a chronic inflammatory skin disorder known to be linked to type 2 diabetes mellitus (T2DM), with 11.6% of psoriasis patien...

read more
Reining in Medicare Spending on Skin Substitutes: What the 2026 Reforms Mean for Dermatology

Published online July 27, 2026

Medicare Part B spending on skin substitute products rose from $256 million in 2019 to more than $10 billion in 2024. 1 A 2025 brief r...

read more
Speed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis

Published online July 20, 2026

Psoriasis is a chronic, immune-mediated inflammatory condition that affects approximately 3% of the adult population in the United Stat...

read more
Assessing Accuracy of ChatGPT in Identifying Contact Allergens in Commonly Prescribed Topical Therapies for Psoriasis

Published online July 20, 2026

To the Editor, Eight percent (8%) of adults are affected by contact allergies. 1 Patch testing is the gold standard for diagnosis of allergic cont...

read more
Comprehensive Analysis of Comorbidities Associated With Psoriasis Diagnosis in the MEPS National Cohort

Published online July 20, 2026

Dear Editor, Psoriasis is recognized as a systemic disease with various comorbidities that increase disease burden and complicate treatment. 1 R...

read more
Risankizumab Associated With Lower Incident Depression and Sleep Disorders in Psoriasis: A TriNetX Study

Published online July 17, 2026

To the Editor, Psoriasis (PsO) is a chronic inflammatory disease associated with significant psychiatric comorbidity. 1 Emerging evidence sugges...

read more
Biologics for Pediatric Hidradenitis Suppurativa: An Update on the Evolving Therapeutic Landscape

Published online July 16, 2026

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent nodules, abscesses, and sinus tracts th...

read more
Sun Protection: Beyond Sunscreen

Published online July 14, 2026

Ultraviolet (UV) radiation from sun exposure causes photosensitivity, photoaging, and photocarcinogenesis. 1 While dermatologists rout...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

JDD Re:View With Dr. Beer

| Featured Articles, JDD Re:View, Latest News, Skin of Color | No Comments
Skin of Color: Bridging the Knowledge Gap As the patient population becomes more diverse in the United States, it is becoming increasingly important for dermatologists to be comfortable counseling patients…

La Roche-Posay: Intercepting Melanin Precursors for Next-Generation Dark Spot Correction

| Featured Articles, The Latest, Webinars on Demand | No Comments
Join Janiene Luke, MD, to discover how MELAB3’s breakthrough active, Melasyl (2 MNG), intercepts melanin precursors before they form dark spots, setting a new standard for safety and efficacy across…

New Video Abstract: Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss

| Featured Articles, The Latest, Video Abstract | No Comments
Hair loss is a widespread condition with a potentially severe psychological burden, especially among women. The chance of suffering from female alopecia increases with menopause, and topical treatments beyond minoxidil…

JDD in the News: Ruxolitinib vs. Triamcinolone for Atopic Dermatitis

| Featured Articles, JDD in the Media, Latest News | No Comments
MedPage Today/Dermatology World Weekly highlighted a Journal of Drugs in Dermatology study comparing a topical JAK inhibitor with a common topical steroid in atopic dermatitis (AD). The study, “Ruxolitinib Cream…

The PASI Paradigm Shift: How Higher Clinical Trial Endpoints Are Reshaping Dermatology

| Dermatology Podcast Archives, Featured Articles, Latest News, Podcast, Podcast Highlights | No Comments
Remember when PASI 75 was the gold medal? Today, it barely makes the podium. In this episode of the JDD Podcast, host Dr. Adam Friedman welcomes Dr. James Song for…
Journal of Drugs in Dermatology JDD featuring Safety and Effectiveness of Poly-L-Lactic Acid (PLLA-SCA) for Improvement in the Appearance of Cellulite

Safety and Effectiveness of Poly-L-Lactic Acid (PLLA-SCA) for Improvement in the Appearance of Cellulite

| Aesthetics, Featured Articles, Latest News, Skincare | No Comments
New JDD Data Explore PLLA-SCA for Posterior Thigh Cellulite  Have you read this article from the JDD? A new 12 month study is drawing attention for practicing dermatologists and dermatology…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Saving Skin, Hair & Nails with Supportive Oncodermatology: A Call to Action for All Those Involved

| Featured Podcast, Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Mario E. Lacouture, MD & Adam Friedman, MD, FAAD   While the old adage, "more oncology treatments, more skin problems," becomes more like dogma every…
Tune In

Follow Us